PHARMACIE DE VISSCHER
ActivePHARMACIE DE VISSCHER has been active since 2000 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.59M and a net result of €204k. Equity is growing by ~8.6% per year across the filed fiscal years. Its solvency ranks better than 95% of 10345 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Checked score
Score 2025
82
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability84▼-3
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.8%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €130k at 30 days acceptable
Liquidity ample (current ratio 23.85 against 19.53 in 2024; short-term debt: 4.1% and cash: 19.9% of total assets), and 4.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
95.8%
Return on assets
12.3%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-08-2026, 30 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
30 d late
2024
70 d late
2023
110 d late
2022
32 d late
2021
30 d late
2020
on the day
2019
146 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
22-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Source amounts without an identifiable currency are assumed to be EUR.
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€204k▼ 12.4%
2024 · €233k
2018: €146k
2019: €153k
2020: €216k
2021: €200k
2022: €187k
2023: €203k
2024: €233k
2018 → 2025
Working capital
€1.55M▲ 4.6%
2024 · €1.48M
2018: €712k
2019: €870k
2020: €1.09M
2021: €1.27M
2022: €1.31M
2023: €1.38M
2024: €1.48M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€1.33M-€1.38M▲ 3.9%€1.44M▲ 4.6%€1.53M▲ 6.4%€1.59M▲ 3.8%
Operating result€289k-€273k▼ 5.5%€273k▲ 0.2%€306k▲ 12.0%€276k▼ 9.8%
Net result€200k-€187k▼ 6.1%€203k▲ 8.5%€233k▲ 14.5%€204k▼ 12.4%
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 10% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.66M
Fixed assets
€44k▼ 18.3%
Current assets
€1.62M▲ 3.6%
Equity and liabilities €1.66M
Equity
€1.59M▲ 3.8%
Debt
€69k▼ 14.7%
The debt ratio falls from 5.0% to 4.2%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€290k▼
2024 · €320k
Cash flow
€217k▼
2024 · €246k
Solvency
95.8%▲
2024 · 95.0%
Current ratio
23.85▲
2024 · 19.53
Quick ratio
22.11▲
2024 · 17.99
Debt / equity
0.04▼
2024 · 0.05
ROE
12.8%▼
2024 · 15.2%
ROA
12.3%▼
2024 · 14.4%
Interest coverage
110.96▼
2024 · 147.23
Debt
€69k▼
2024 · €81k
Debt ≤ 1 year
€68k▼
2024 · €80k
Income taxes
€89k▼
2024 · €103k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1.61M€1.66M▲
Fixed assets21/28€54k€44k▼
Tangible fixed assets22/27€54k€44k▼
Land and buildings22€19k€17k▼
Plant, machinery and equipment23€3k€3k▼
Furniture and vehicles24€13k€6k▼
Other tangible fixed assets26€19k€19k▲
Current assets29/58€1.56M€1.62M▲
Stocks and contracts in progress3€123k€118k▼
Stocks30/36€123k€118k▼
Amounts receivable within one year40/41€146k€161k▲
Trade receivables40€107k€117k▲
Other amounts receivable41€38k€44k▲
Current investments50/53€900k€1.00M▲
Cash at bank and in hand54/58€379k€331k▼
Deferred charges and accrued income490/1€13k€8k▼
Equity and liabilities
Total equity and liabilities10/49€1.61M€1.66M▲
Equity10/15€1.53M€1.59M▲
Contributions10/11€6k€6k=
Reserves13€1.40M€1.45M▲
Non-distributable reserves130/1€17k€17k=
Other1319€17k€17k=
Distributable reserves133€1.38M€1.44M▲
Profit (loss) carried forward14€131k€131k=
Amounts payable17/49€81k€69k▼
Amounts payable within one year42/48€80k€68k▼
Trade debts44€33k€21k▼
Suppliers440/4€33k€21k▼
Advances received on contracts in progress46-€236
Taxes, remuneration and social security45€23k€22k▼
Taxes450/3€23k€22k▼
Other amounts payable47/48€24k€24k▲
Accrued charges and deferred income492/3€1k€2k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€14k€14k▼
Other operating charges640/8€3k€4k▲
Gross operating margin9900€323k€294k▼
Operating profit (loss)9901€306k€276k▼
Financial income75/76B€31k€19k▼
Recurring financial income75€31k€19k▼
Financial charges65/66B€2k€3k▲
Recurring financial charges65€2k€3k▲
Profit (loss) for the period before taxes9903€335k€293k▼
Income taxes67/77€103k€89k▼
Profit (loss) for the period9904€233k€204k▼
Profit (loss) for the period to be appropriated9905€233k€204k▼
Appropriation of the result
Profit (loss) to be appropriated9906€363k€334k▼
Profit (loss) brought forward from the previous period14P€131k€131k=
Transfer from equity791/2€140k-
Transfer to equity691/2€233k€204k▼
To other reserves6921€233k€204k▼
Profit to be distributed694/7€140k-
Return on contributions (dividend)694€140k-
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 30 days late
2025
09-10
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 70 days late
2024
31-12
Financial
Highest result since 2018net €233k ▲14.5%
Net result €233k, the highest in the series.
18-11
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 110 days late
2023
01-09
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 32 days late
2022
30-08
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 30 days late
2021
31-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Liquidity quadruplescurrent ratio 24.48
Current ratio from 6.24 to 24.48; short-term debt falls from €166k to €46k.
31-12
Financial
Equity above €1MEq €1.13M ▲23.7%
3 profitable years in a row build equity to €1.13M.
24-12
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 146 days late
2019
29-07
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
07-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 7 days late
2017
29-07
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Anderlecht · 1 establishment unit since 2000
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rossinistraat 31070 AnderlechtGround area
96 m²
Building footprint
82 m²
Volume, LiDAR
1,079 m³
Parcel 21305B0258/00B008, Brussels · tallest building 17.2 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
Rossinistraat 3, 1070 Anderlecht
since 20002.096.617.287
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21305B0258/00B008 | Brussels | 96 m² | 1 · 82 m² | 17.2 m · 5 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteAnderlecht2.096.617.287
Similar companies · same sector, comparable size
FARMAGORA
BE 0436.025.193
Ternat · Eq €1.59M
BB FARMA MANAGEMENT
BE 0861.674.655
Riemst · Eq €1.60M
FIMOVAR
BE 0462.346.837
Niel · Eq €1.61M
Apotheek An Sofie Stragier
BE 0472.709.605
Brugge · Eq €1.57M
K & K MANAGEMENT
BE 0881.071.586
Mol · Eq €1.57M
Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 2,609 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company (pre-2019)
Founded21-03-2000
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 26 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.